Home / Market Reports / Pharma & Healthcare
/ Global Refined Guanxin Tablets Market Growth 2024-2030
Global Refined Guanxin Tablets Market Growth 2024-2030
Product Code:1241782
Published Date: Nov 29,2024
Pages: 75
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
The global Refined Guanxin Tablets market size is predicted to grow from US$ 42.8 million in 2024 to US$ 60.3 million in 2030; it is expected to grow at a CAGR of 5.9% from 2024 to 2030.
Refined Guanxin Tablets are a Chinese patent medicine, mainly composed of Danshen, Chuanxiong, Red Peony Root, Curcuma, Panax Notoginseng, Choerospondias, Safflower, Borneol, etc. It has the effects of promoting blood circulation and removing blood stasis, regulating qi and relieving pain. It is specially used to treat coronary heart disease, angina pectoris, myocardial infarction, heart failure, arrhythmia, palpitation and shortness of breath, and atrial fibrillation caused by various reasons.
United States market for Refined Guanxin Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Refined Guanxin Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Refined Guanxin Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Refined Guanxin Tablets players cover Guangdong Yishu Pharmaceutical Co., Ltd., Guangdong Heping Pharmaceutical Co., Ltd., Guangxi Jinhaitang Pharmaceutical Co., Ltd., Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd., Guangxi Weiwei Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
LP Information, Inc. (LPI) ' newest research report, the “Refined Guanxin Tablets Industry Forecast” looks at past sales and reviews total world Refined Guanxin Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Refined Guanxin Tablets sales for 2024 through 2030. With Refined Guanxin Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Refined Guanxin Tablets industry.
This Insight Report provides a comprehensive analysis of the global Refined Guanxin Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Refined Guanxin Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Refined Guanxin Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Refined Guanxin Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Refined Guanxin Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Refined Guanxin Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Film-coated Tablets
Sugar-coated Tablets
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Guangdong Yishu Pharmaceutical Co., Ltd.
Guangdong Heping Pharmaceutical Co., Ltd.
Guangxi Jinhaitang Pharmaceutical Co., Ltd.
Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd.
Guangxi Weiwei Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Refined Guanxin Tablets market?
What factors are driving Refined Guanxin Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Refined Guanxin Tablets market opportunities vary by end market size?
How does Refined Guanxin Tablets break out by Type, by Application?